The Academic Minute from 03.09 – 03.13
Monday, March 9th
Libusha Kelly – Albert Einstein College of Medicine
Gut Microbiome and Adverse Drug Reactions
Libusha Kelly, Ph.D., is associate professor of systems & computational biology and of microbiology and immunology. Dr. Kelly’s background in structural biology, machine learning, information theory, high throughput genomics, metabolomics, and microbial ecology, allows her to bridge the gap between fundamental questions in the ecology of complex communities of microbes and clinical applications of microbiome research.
Tuesday, March 10th
Chaim Putterman – Albert Einstein College of Medicine
Diagnosing Lupus Nephritis
Dr. Chaim Putterman is a clinical rheumatologist who treats arthritis and related musculoskeletal and autoimmune diseases. Dr. Putterman specializes in lupus, an incurable autoimmune disease affecting hundreds of thousands of Americans that causes inflammation, pain, and damage to various parts of the body.
Wednesday, March 11th
Ulrich Steidl – Albert Einstein College of Medicine
Dr. Ulrich Steidl is professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Albert Einstein College of Medicine. He is also associate Chair for translational research in oncology at Montefiore Health System. Dr. Steidl’s research focuses on identifying critical mechanisms that drive the development of deregulated stem cells known as leukemia stem cells. As part of his research on the stem cell origin of myeloid malignancies including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), his laboratory has developed and refined unique experimental tools for functional and mechanistic studies including in transcriptional and epigenetic regulation and at the stem cell level, as well as novel approaches for their specific therapeutic targeting. Dr. Steidl has published his findings in prominent journals including Nature, Nature Medicine, Nature Immunology, Nature Chemical Biology, Science Translational Medicine, Cancer Cell, and others. Among his important contributions to the field are investigations and discoveries of cellular and molecular regulatory mechanisms in precancerous stem cells in MDS, AML, and myeloproliferative neoplasms (MPN).
Thursday, March 12th
Jill Crandall – Albert Einstein College of Medicine
Dr. Crandall is professor and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Albert Einstein College of Medicine, and chief of the division of endocrinology at Einstein and Montefiore Health System. She is director of the Fleischer Institute for Diabetes and Metabolism and director of the Diabetes Clinical Trials Unit. Dr. Crandall is also a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE), and the Preventing Early Renal Loss (PERL) study.
Friday, March 13th
Sophie Molholm – Albert Einstein College of Medicine
Sensory Integration Therapy
Dr. Sophie Molholm is professor of pediatrics, of neuroscience, and of psychiatry and behavioral sciences at Albert Einstein College of Medicine. She is also associate director of the Rose F. Kennedy Intellectual and Developmental Research Center at Einstein. She also directs the Human Clinical Phenotyping Core.
Dr. Molholm is interested in how the brain works, and gives rise to our experience in the world. She studies basic processes such as how the human brain processes and integrates sensory inputs to impact perception and behavior, mechanisms of attention, how speech processing is achieved, and higher-order cognition related to executive function.